Preventing Hepatitis C in Prisons: The Role of Opioid Agonist Treatment (OAT)

Webpage link: https://ashm.org.au/education/preventing-hepatitis-c-in-prisons/

Course dates: Tuesday, 24 June 2025
Course time and timezone/s: 

• 12:00–1:30 PM (AEST: NSW, VIC, ACT, TAS, QLD)
• 11:30 AM–1:00 PM (ACST: SA, NT)
• 10:00–11:30 AM (AWST, WA)

Event description:

ASHM, in collaboration with the National Prisons Hepatitis Network, invites you to a free national Lunch & Learn webinar exploring the critical role of Opioid Agonist Treatment (OAT) in preventing hepatitis C (HCV) in correctional settings. Delivered by experts from across the country, the session features insights from the authors of the National Consensus Statement on OAT in custodial settings, alongside real-world experiences from New South Wales and Queensland correctional programs.

Designed for healthcare professionals, peer workers, policymakers, and anyone working to improve health in correctional settings.

Learning outcomes:

To explore best practice recommendations for Opioid Agonist Therapy (OAT) implementation in prisons in the context of hepatitis C prevention.

By the end of this webinar, participants will be able to:

• Describe the role of OAT as a key enabler for hepatitis C prevention in custodial settings.
• Explore opportunities to expand and sustain OAT delivery through real-world implementation strategies.
• Highlight successful models of OAT integration and practical insights from prison-based programs.

Endorsement and CPD:

RACGP: Pending accreditation with RACGP. ASHM is an RACGP-accredited CPD Provider under the RACGP CPD Program. 

Funding:

This event is supported by an unconditional education grant from Gilead Sciences. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.
Contact email: education@ashm.org.au

Contact phone number: 0431 320 429